NeuroPace (NPCE) Other Working Capital Changes (2020 - 2026)
NeuroPace (NPCE) recorded quarterly Other Working Capital Changes of $77000.0 in Q1 2026, up 115.19% quarter-over-quarter from -$507000.0 in Q4 2025, and down 37.9% on a YoY basis from $124000.0 in Q1 2025.
NeuroPace (NPCE) Other Working Capital Changes (2020 - 2026) Analysis & Trends
NeuroPace's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at $77000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 37.9% year-over-year to $77000.0; the TTM figure through Mar 2026 stood at -$461000.0 (up 58.43% YoY), while the FY2025 annual figure was -$414000.0, up 74.55% from the prior year.
- Other Working Capital Changes was $77000.0 for Q1 2026 at NeuroPace, up from -$507000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.6 million in Q2 2022 to a low of -$1.4 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged -$152176.5 across 5 years, with a median of -$259000.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes plunged 331.59% in 2023, then soared 2287.5% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $611000.0 in 2022, then slumped by 331.59% to -$1.4 million in 2023, then advanced by 28.9% to -$1.0 million in 2024, then surged by 49.6% to -$507000.0 in 2025, then jumped by 115.19% to $77000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $77000.0 (Q1 2026), -$507000.0 (Q4 2025), and $764000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | NeuroPace | 527.50 Mn | 473.52 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77,000.00 |
| Mar 31, 2026 | 77,000.00 |
| Dec 31, 2025 | -507,000.00 |
| Dec 31, 2025 | -507,000.00 |
| Sep 30, 2025 | 764,000.00 |
| Sep 30, 2025 | 764,000.00 |
| Jun 30, 2025 | -795,000.00 |
| Jun 30, 2025 | -795,000.00 |
| Mar 31, 2025 | 124,000.00 |
| Mar 31, 2025 | 124,000.00 |
| Dec 31, 2024 | -1.01 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Sep 30, 2024 | 32,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | -259,000.00 |
| Jun 30, 2024 | -259,000.00 |
| Mar 31, 2024 | -394,000.00 |
| Mar 31, 2024 | -394,000.00 |
| Dec 31, 2023 | -1.42 Mn |
| Dec 31, 2023 | -1.42 Mn |